ARICI, Bruna
 Distribuzione geografica
Continente #
EU - Europa 1.807
NA - Nord America 1.505
AS - Asia 643
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 7
AF - Africa 6
SA - Sud America 4
Totale 3.986
Nazione #
US - Stati Uniti d'America 1.483
DE - Germania 576
CN - Cina 405
PL - Polonia 337
UA - Ucraina 336
IT - Italia 170
IN - India 93
FI - Finlandia 79
GB - Regno Unito 76
HK - Hong Kong 71
FR - Francia 70
RU - Federazione Russa 55
IE - Irlanda 50
SE - Svezia 30
SG - Singapore 25
CA - Canada 21
BE - Belgio 17
TR - Turchia 14
VN - Vietnam 14
EU - Europa 13
AU - Australia 7
IR - Iran 5
TH - Thailandia 4
ID - Indonesia 3
MU - Mauritius 3
NL - Olanda 3
BD - Bangladesh 2
KZ - Kazakistan 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BR - Brasile 1
CL - Cile 1
CZ - Repubblica Ceca 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
TZ - Tanzania 1
VE - Venezuela 1
Totale 3.986
Città #
Warsaw 337
Jacksonville 239
Chandler 115
Fairfield 114
Woodbridge 105
Ann Arbor 102
Ashburn 96
Princeton 96
Nanjing 95
Wilmington 81
Beijing 73
Hong Kong 70
Houston 68
New York 64
Cambridge 62
Dearborn 49
Dublin 49
Seattle 40
Nanchang 35
Helsinki 33
Brescia 30
Shenyang 27
Hebei 22
Tianjin 22
Changsha 21
Jinan 20
Des Moines 18
Brussels 16
Jiaxing 15
Pune 13
Dong Ket 12
Lancaster 12
Milan 12
Kocaeli 11
Kunming 11
Toronto 11
Hangzhou 10
North York 9
Nürnberg 9
San Diego 8
San Francisco 8
Shanghai 8
Verona 8
Ningbo 7
Boardman 5
Guangzhou 5
Haikou 5
Los Angeles 5
Singapore 5
Taizhou 5
Zhengzhou 5
Melbourne 4
Napoli 4
Borås 3
Castelnuovo Bozzente 3
Hefei 3
Lanzhou 3
Norwalk 3
Orange 3
Phoenix 3
Rome 3
Treviglio 3
Amsterdam 2
Augusta 2
Berlin 2
Catanzaro 2
Colliano 2
Copertino 2
Duncan 2
Ferrara 2
Fuzhou 2
Gardone Riviera 2
Jakarta 2
Lappeenranta 2
Lecco 2
London 2
Parma 2
Perugia 2
Santa Caterina Dello Ionio 2
Sydney 2
Acireale 1
Almaty 1
Astana 1
Bangkok 1
Barlassina 1
Belpasso 1
Borgo Di Terzo 1
Bras 1
Bratislava 1
Brooklyn 1
Bryansk 1
Canberra 1
Carpi 1
Central 1
Changchun 1
Chongqing 1
Cochin 1
Colleferro 1
Dhaka 1
Gandra 1
Totale 2.389
Nome #
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 276
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 213
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 180
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 156
Preparazione di colture primarie di fibroblasti di embrione di pollo . 144
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 132
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 126
microRNAs and human hepatocellular carcinoma 122
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 109
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 107
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 107
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 101
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 100
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 95
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 93
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 85
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 75
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 74
Urokinase and c-met are target of miR-23b in human cells. 72
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 72
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 69
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 67
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 66
"Trasformazione indotta dai virus oncogeni ad RNA. Tecniche di produzione e titolazione del RSV in colture di fibroblasti di embrione di pollo" pp. 27- 34, settembre 1987, in: , CLEUP-Padova, Italia. 66
Il microRNA-23b media la downmodulazione di urochinasi e met ed inibisce la migrazione di cellule umane derivate da epatocarcinoma cellulare. 64
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 62
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 62
miR-23b down-regulates urokinase and c-met expression and inhibits migration of human hepatocellular carcinoma cells. 61
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 61
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 61
MET silencing in human hepatocellular carcinoma: antisense and RNA interference 60
RNA interference for urokinase gene in human hepatocellular carcinoma 60
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 60
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 59
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 59
miR-23b regulates uPA and c-met expression and mediates inhibition of HCC cells migration and proliferation. 58
Targeted therapy for human hepatocellular carcinoma (HCC): RNA interference for urokinase targeting in HCC xenografts in nude mice 58
Strategie ablative per il silenziamento genico di c-met nell'epatocarcinoma cellulare umano: tecnologia antisenso ed RNAi. 57
MicroRNA-23b mediates urokinase and MET downmodulation and inhibits migration of human hepatocellular carcinoma cells. 57
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma 56
MicroRNA-23b downmodulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 55
Tecniche di conservazione delle cellule mediante congelamento. 53
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 51
L'espressione stabile di siRNA per il gene urochinasi diminuisce la capacità invasiva e di migrazione di cellule di epatocarcinoma cellulare umano. 51
Molecular therapies for hepatocellular carcinoma: silencing of urokinase-type plasminogen activator by antisense and siRNA stable u-PA expression 51
RNA interference per il gene urochinasi nell'epatocarcinoma cellulare umano 49
Profilo proteomico di cellule umane tumorali epatiche dopo silenziamento genico di urochinasi mediante RNAi 48
RNA interference for urokinase targeting limits growth of hepatocellular carcinoma xenografts in nude mice 45
The down-modulation of miR-23b in hepatocellular carcinoma is mediated by DNA methylation 14
Totale 4.079
Categoria #
all - tutte 13.922
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.922


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201981 0 0 0 0 0 0 0 0 0 0 46 35
2019/20201.058 159 37 41 92 45 124 116 114 51 157 63 59
2020/2021591 14 76 13 66 15 68 19 81 109 55 54 21
2021/2022356 9 66 10 26 2 9 10 23 17 35 50 99
2022/2023339 61 13 13 32 31 88 0 24 45 2 15 15
2023/2024309 20 12 28 10 26 90 36 7 72 6 2 0
Totale 4.079